Peter Bell

机构：Integrated BioTherapeutics (United States) · ORCID：0000-0002-5420-4477

发表论文 120 篇 · 总被引 8423 次 · h-index 52

代表论文

• The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier (2019 · Molecular Therapy · 被引 230)
• MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates (2020 · Science Translational Medicine · 被引 179)
• Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration (2023 · Nature Biotechnology · 被引 136)
• Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques (2018 · Molecular Therapy — Methods & Clinical Development · 被引 109)
• Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques (2018 · Molecular Therapy — Methods & Clinical Development · 被引 86)
• Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys (2019 · Human Gene Therapy · 被引 78)